Compile Data Set for Download or QSAR
Report error Found 43 Enz. Inhib. hit(s) with all data for entry = 9372
TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249344(US9463192, 21-51 | US9763943, 21-51 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249334(US9463192, 15-87 | US9763943, 15-87 | US9993479, 1...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249339(US9463192, 21-1 | US9763943, 21-1 | US9993479, 21-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249340(US9463192, 21-2 | US9763943, 21-2 | US9993479, 21-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249341(US9463192, 21-9 | US9993479, 21-9 | US10300060, Ex...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249342(US9463192, 21-13 | US9763943, 21-13 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249343(US9463192, 21-37 | US9763943, 21-37 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249355(US9463192, 23-12 | US9763943, 23-12 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249350(US9463192, 22-8 | US9763943, 22-8 | US9993479, 22-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249356(US9463192, 22-9 | US9763943, 22-9 | US9993479, 22-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249351(US9463192, 22-34 | US9763943, 22-34 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249357(US9463192, 23-3 | US9763943, 23-3 | US9993479, 23-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249353(US9463192, 23-10 | US9763943, 23-10 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249354(US9463192, 23-11 | US9763943, 23-11 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249315(US9463192, 7 | US9763943, 7 | US9993479, 7 | US103...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249316(US9463192, 8-1 | US9763943, 8-1 | US9993479, 8-1 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249318(US9463192, 8-4 | US9763943, 8-4 | US9993479, 8-4 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249320(US9463192, 9-2 | US9763943, 9-2 | US9993479, 9-2 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249321(US9463192, 11 | US9763943, 11 | US9993479, 11 | US...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249325(US9463192, 15-4 | US9763943, 15-4 | US9993479, 15-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249324(US9463192, 14-6 | US9763943, 14-6 | US9993479, 14-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249323(US9463192, 14-5 | US9763943, 14-5 | US9993479, 14-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249332(US9463192, 15-71 | US9763943, 15-71 | US9993479, 1...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249317(US9463192, 8-2 | US9763943, 8-2 | US9993479, 8-2 |...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249352(US9463192, 23-7 | US9763943, 23-7 | US9993479, 23-...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249322(US9463192, 13-1 | US9763943, 13-1 | US9993479, 13-...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249347(US9463192, 21-70 | US9763943, 21-70 | US9993479, 2...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249327(US9463192, 15-6 | US9763943, 15-6 | US9993479, 15-...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249330(US9463192, 15-58 | US9763943, 15-58 | US9993479, 1...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249331(US9463192, 15-63 | US9763943, 15-63 | US9993479, 1...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249333(US9463192, 15-77 | US9763943, 15-77 | US9993479, 1...)
Affinity DataIC50: 2nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249326(US9463192, 15-5 | US9763943, 15-5 | US9993479, 15-...)
Affinity DataIC50: 3nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249348(US9463192, 21-73 | US9763943, 21-73 | US9993479, 2...)
Affinity DataIC50: 3nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249319(US9463192, 9-1 | US9763943, 9-1 | US9993479, 9-1 |...)
Affinity DataIC50: 3nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249346(US9463192, 21-67 | US9763943, 21-67 | US9993479, 2...)
Affinity DataIC50: 4nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249349(US9463192, 21-75 | US9763943, 21-75 | US9993479, 2...)
Affinity DataIC50: 4nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249328(US9463192, 15-52 | US9763943, 15-52 | US9993479, 1...)
Affinity DataIC50: 4nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249329(US9463192, 15-55 | US9763943, 15-55 | US9993479, 1...)
Affinity DataIC50: 4nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249338(US9463192, 15-105 | US9763943, 15-105 | US9993479,...)
Affinity DataIC50: 4nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent